BioLife Solutions, Inc. (BLFS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.88+0.02 (+1.05%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close1.86
Bid1.47 x 1000
Ask2.65 x 100
Day's Range1.86 - 1.90
52wk Range1.46 - 4.18
1y Target EstN/A
Market Cap24.16M
P/E Ratio (ttm)-4.86
Avg Vol (3m)396,562
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • TheStreet.com2 days ago

    These 5 Stocks Under $10 Could Make You a Lot of Money

    Here's a technical look at how to trade several under-$10 stocks that are within range of triggering big breakouts.

  • PR Newswire3 days ago

    BioLife Solutions' CryoStor® Integrated in Kolon Group's Cell-Mediated Gene Therapy for Osteoarthritis

    BOTHELL, Wash., Aug. 24, 2016 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers ("BioLife" or the "Company"), today announced that its clinical grade CryoStor freeze media has been incorporated into the manufacturing process for Invossa, a cell-mediated gene therapy for knee osteoarthritis to be marketed by Kolon Life Science. According to Kolon, Invossa is the world's first cell-mediated gene therapy for osteoarthritis, a degenerative joint disease affecting more than 150 million people.

  • Capital Cube11 days ago

    ETF’s with exposure to BioLife Solutions, Inc. : August 16, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to BioLife Solutions, Inc. Here are 5 ETF’s with the largest exposure to BLFS-US. Comparing the performance and risk of BioLife Solutions, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)